Top Industry Leaders in the Brucellosis Market
Latest Brucellosis Companies Update
March 2023:Zoetis Inc. receives Conditional Marketing Authorization from the European Commission for BOVIGAM® (recombinant Brucella abortus strain S19ΔH gene-deleted live attenuated vaccine) for use in cattle.June 2022:The US Department of Agriculture approves MegaloB-RPA as a rapid Brucellosis detection test for livestock.October 2023:Researchers at the University of Texas at Austin publish promising results from a study evaluating the potential of a new Brucella melitensis vaccine candidate.November 2022:The World Health Organization launches a research initiative to develop new diagnostic tools and treatment options for Brucellosis.February 2024:The International Society for Veterinary Epidemiology and Economics (ISVEE) will host a session on brucellosis control and eradication at their annual conference.September 2023:The World Organisation for Animal Health (OIE) holds a regional workshop on brucellosis control and prevention strategies in Southeast Asia.
List of Brucellosis Key Companies in the Market
- Hester Biosciences Limited
- ATA FEN Inc.
- Biogénesis-Bagó S.A.
- Biopharma
- Biovet
- Calier & Biologicos Laverlam
- Merck Animal Health (MSD Animal Health)
- Colorado Serum Company
- Indian Immunologicals Limited
- Dollvet
- Veterinary Technologies Corporation
- China Animal Husbandry Co. Ltd. (CAHIC)
- LABIOFAM
- BCG Vaccine Laboratory